Award will provide advanced instrumentation to unlock
the secrets of pancreatic cancer metabolism
MD Anderson News Release 03/29/13
Pancreatic cancer is one the deadliest and hardest to treat cancers.
In recognition of his leadership of an innovative translational
research program targeted at pancreatic cancer, Ronald DePinho, M.D.,
president of The University of Texas MD Anderson Cancer Center, was selected...